Alemtuzumab induction combined with reduced maintenance immunosuppression is associated with improved outcomes after lung transplantation: A single centre experience

QUESTION ADDRESSED BY THE STUDY: The value of induction therapy in lung transplantation is controversial. According to the ISHLT, only about 50% of patients transplanted within the last 10 years received induction therapy. We reviewed our institutional experience to investigate the impact of inducti...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Benazzo, Alberto, Schwarz, Stefan, Muckenhuber, Moritz, Schweiger, Thomas, Muraközy, Gabriela, Moser, Bernhard, Sigüenza, José Matilla, Lang, György, Taghavi, Shahrokh, Klepetko, Walter, Hoetzenecker, Konrad, Jaksch, Peter, Lambers, Cristopher
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6333331/
https://ncbi.nlm.nih.gov/pubmed/30645645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0210443
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia